AN2 Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AN2 Therapeutics, Inc.
CIK #0001880438
EDGAR Form CIK 2011 - 2025
10-K [0001880438]
10-Q [0001880438]
3 [0001880438]
4 [0001880438]
8-K [0001880438]
SC 13D [0001880438]
SC 13G [0001880438]
Form 13D/13G Filer Form 13D/13G Subject Filed
Coastlands Capital Partners LP AN2 Therapeutics Inc [2025-06-04]
BML Investment Partners LP AN2 Therapeutics Inc [2025-05-07]
BML Investment Partners LP AN2 Therapeutics Inc [2024-08-12]
Octagon Capital Advisors LP AN2 Therapeutics Inc [2024-07-03]
Frazier Life Sciences Public Fund LP AN2 Therapeutics Inc [2024-04-10]
Easom Eric AN2 Therapeutics Inc [2024-02-13]
TCG Crossover GP I LLC AN2 Therapeutics Inc [2023-07-25]
Janus Henderson Group PLC AN2 Therapeutics Inc [2023-07-05]
Pfizer Inc AN2 Therapeutics Inc [2023-02-13]
BRII Biosciences Ltd AN2 Therapeutics Inc [2023-02-13]
View All
Form 3/4/5 Subject 2011 - 2025
Martin Patricia A.
AN2 Therapeutics, Inc.
Marks Gilbert Lynn
Aziz Kabeer
Leonard Braden Michael
Easom Eric
FitzPatrick Margaret M
Readnour Robin Shane
Zakrzewski Joseph S
Spigelman Melvin K
View All
Terms | Privacy | Guide
tony@aum13f.com